Affiliation:
1. *Dermatology and
2. ‡Veterans Affairs Medical Center, Milwaukee, WI 53295
3. †Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226; and
Abstract
Abstract
Autoantibodies associated with herpes gestationis (HG), a pregnancy-associated autoimmune skin disease, target the hemidesmosomal protein BP180. It was shown that the major noncollagenous stretch of the BP180 ectodomain (NC16A) harbors epitopes recognized by HG sera. Furthermore, Abs reactive with the homologous domain of murine BP180 are known to trigger a cutaneous blistering disease in mice by passive transfer experiments. The present study was aimed at characterizing the T cell responses and specificities of autoantibodies from two HG patients. Using immunoblotting and T cell proliferation assays, we have identified a 14-amino-acid stretch of the BP180 ectodomain (MCW-1; aa 507–520) that is recognized by both T cells and autoantibodies produced by the HG patients. The neonate born to one of these HG patients showed no signs of skin disease and had no detectable T cell response to the BP180 Ag, but did have a low titer of circulating anti-BP180 autoantibodies, presumably of maternal origin. BP180-specific T cell lines and clones developed from an HG patient specifically reacted with the MCW-1 epitope. The proliferative responses of these clones were restricted to HLA-DR, but not -DQ or -DP. These Ag-specific T cells expressed α/β TCRs and a CD4 memory T cell phenotype and secreted IFN-γ and IL-2, but not IL-4 or IL-6, suggesting that they are Th1-type lymphocytes. Further characterization of these Ag-specific T cells and autoantibodies will aid in elucidating the autoimmune mechanism(s) leading to the development of HG.
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Reference47 articles.
1. Shornick, J. K., J. L. Bangert, R. G. Freeman, J. N. Gilliam. 1983. Herpes gestationis: clinical and histological features of twenty-eight cases. J. Am. Acad. Dermatol. 8: 214
2. Provost, T. T., T. B. Tomasi, Jr. 1973. Evidence for complement activation via the alternative pathway in skin diseases. I. Herpes gestationis, systemic lupus erythematosus and bullous pemphigoid. J. Clin. Invest. 51: 1779
3. Jordon, R. E., K. G. Heine, G. Tappeiner, L. L. Bushkell, T. T. Provost. 1976. The immunopathology of herpes gestationis: immunofluorescent studies and characterization of the “HG” factor. J. Clin. Invest. 57: 1426
4. Katz, S. I., K. C. Hertz, H. Yaoita. 1976. Herpes gestationis: immunopathology and characterization of the HG factor. J. Clin. Invest. 57: 1434
5. Carruthers, J. A., A. R. Ewins. 1978. Herpes gestationis: studies on the binding characteristics, activity, and pathogenetic significance of the complement-fixing factor. Clin. Exp. Immunol. 31: 38